TI RISK
Live / Registered — Registered — Section 8 accepted (as of 02 May 2026)
What this means for you
Registered since 17 Dec 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Dec 2029: the §8 & §9 renewal).
Record
- Serial number
- 87722787
- Registration number
- 5938641
- Mark type
- Word mark
- Filed
- 15 Dec 2017
- Published for opposition
- 12 Jun 2018
- Registered
- 17 Dec 2019
- Next maintenance filing
- §8 & §9 renewal, due by 17 Dec 2029 (grace period to 17 Jun 2030)
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software that is used to identify and provide use ratings for health care practitioners that are engaged in the business of prescribing opioids and/or highly controlled drugs and substances, which operates as both a process and a tool to manage such research related to the identified and health care practitioners
Owner
- QPharma, Inc., Morristown, NJ, US
- QPharma, Inc., Morristown, NJ, US
- QPharma, Inc., Morristown, NJ, US
Prosecution history
- 02 May 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 02 May 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 02 May 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Dec 2025 — TEAS SECTION 8 RECEIVED
- 17 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 13 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Oct 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Oct 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Oct 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Apr 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Apr 2019 — NON-FINAL ACTION E-MAILED
- 23 Apr 2019 — SU - NON-FINAL ACTION - WRITTEN
- 30 Mar 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED